Citation Tools

Download PDFPDF

High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute

Download to a citation manager

Cite this article as:
Davar D, Ding F, Saul M, et al
High-dose interleukin-2 (HD IL-2) for advanced melanoma: a single center experience from the University of Pittsburgh Cancer Institute